Canakinumab treatment real world evidence in 3 monogenic periodic fever syndromes in 2009-2022: an interim analysis using the French JIR cohort database

Vitiligo

Real-world evidence for vitiligo using an electronic medical records database in Spain: the REVEAL-ES study

Eur J Dermatol

Estebaranz JLL, González-Montagut CM, González J, Miguel IAGS, Garcia-Recio V, Callejo D, De Prado A, Delattre C

doi: 10.1684/ejd.2024.4676

Systemic Sclerosis

Tocilizumab and rituximab for systemic sclerosis interstitial lung disease: a real-world cohort analysis

Rheumatology (Oxford)

Goldman NR, Nihtyanova SI, Beesley CF, Wells AU, Denton CP, Renzoni EA, Mageed R, Ong VH

doi: 10.1093/rheumatology/keaf006

Psoriatic Arthritis

Psoriatic arthritis phenotype clusters and their association with treatment response: a real-world longitudinal cohort study from the psoriatic arthritis research consortium

Ann Rheum Dis

Karmacharya P, Crofford LJ, Byrne DW, Stephens-Shields A, Husni ME, Scher JU, Craig E, Fitzsimmons R, Reddy SM, Magrey MN, Walsh JA, Ogdie A

doi: 10.1136/ard-2024-226150

Psoriatic Arthritis

Psoriatic arthritis phenotype clusters and their association with treatment response: a real-world longitudinal cohort study from the psoriatic arthritis research consortium

Ann Rheum Dis

Karmacharya P, Crofford LJ, Byrne DW, Stephens-Shields A, Husni ME, Scher JU, Craig E, Fitzsimmons R, Reddy SM, Magrey MN, Walsh JA, Ogdie A

doi: 10.1136/ard-2024-226150

Melanoma and Skin Cancer

Real-world use and outcomes of targeted therapy and immunotherapy for adjuvant treatment of BRAF-mutated melanoma patients in the United States

Melanoma Res

Chandrasekaran S, Ling YL, Tang J

doi: 10.1097/CMR.0000000000000990

Rheumatoid Arthritis

A phase 3, randomized, double-blind, active-controlled clinical trial to compare BAT1806/BIIB800, a tocilizumab biosimilar, with tocilizumab reference product in participants with moderate-to-severe rheumatoid arthritis with inadequate response to methotrexate: treatment period 2 analysis (week 24 to week 48)

Arthritis Res Ther

Leng X, Leszczyński P, Jeka S, Liu S, Liu H, Miakisz M, Gu J, Kilasonia L, Stanislavchuk M, Yang X, Zhou Y, Dong Q, Mitroiu M, Addison J, Rezk MF, Zeng X

doi: 10.1186/s13075-024-03375-w

Psoriatic Arthritis

Comparison of On-Label Treatment Persistence in Real-World Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Interleukin-17A Inhibitors

Adv Ther

Mease PJ, Ferrante SA, Shiff NJ, Fitzgerald TP, Chakravarty SD, Walsh JA

doi: 10.1007/s12325-024-03042-1

Further Publications Immunology

Effectiveness and safety of methotrexate in the treatment of mycosis fungoides: Real-world data from a multicentre study

J Eur Acad Dermatol Venereol

Nikolaou V, Panou E, Tsimpidakis A, Koumprentziotis IA, Patsatsi A, Siakantaris M, Kruger-Krasagakis SE, Marinos L, Georgiou E, Lampadaki K, Velissari A, Daponte AI, Doxastaki A, Kaliampou S, Vaiopoulos A, Konstandinou I, Koumourtzis M, Lakiotaki E, Pappa V, Tsamaldoupis A, Stratigos A, Papadavid E

doi: 10.1111/jdv.20350

Psoriasis

Management of moderate to severe psoriasis with brodalumab-Real-world evidence from the LIBERO study

J Eur Acad Dermatol Venereol

von Kiedrowski R, Hinz T, Mauer G, Schwinn A, Timmel A, Hutt HJ, Augustin M

doi: 10.1111/jdv.19974

Related content

Real-world evidence for vitiligo using an electronic medical records database in Spain: the REVEAL-ES study

Tocilizumab and rituximab for systemic sclerosis interstitial lung disease: a real-world cohort analysis

Psoriatic arthritis phenotype clusters and their association with treatment response: a real-world longitudinal cohort study from the psoriatic arthritis research consortium

Psoriatic arthritis phenotype clusters and their association with treatment response: a real-world longitudinal cohort study from the psoriatic arthritis research consortium

Real-world use and outcomes of targeted therapy and immunotherapy for adjuvant treatment of BRAF-mutated melanoma patients in the United States

Comparison of On-Label Treatment Persistence in Real-World Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Interleukin-17A Inhibitors

Effectiveness and safety of methotrexate in the treatment of mycosis fungoides: Real-world data from a multicentre study

Management of moderate to severe psoriasis with brodalumab-Real-world evidence from the LIBERO study